MEDIKINET MR 20 MG MODIFIED-RELEASE CAPSULES
Country: Ísrael
Tungumál: enska
Heimild: Ministry of Health
Sum skjöl fyrir þessa vöru eru ekki tiltæk eins og er, þú getur sent beiðni til þjónustu við viðskiptavini okkar og við munum láta þig vita um leið og við getum fengið þau.
Senda beiðni.
Senda beiðni.
Virkt innihaldsefni:
METHYLPHENIDATE HYDROCHLORIDE 20 MG
Fáanlegur frá:
MEDILINE LTD.
ATC númer:
N06BA04
Lyfjaform:
MODIFIED RELEASE CAPSULES
Stjórnsýsluleið:
PER OS
Framleitt af:
MEDICE ARZNEIMITTEL PUETTER GMBH & CO.KG, GERMANY
Meðferðarhópur:
METHYLPHENIDATE
Ábendingar:
Medikinet Modified Release Capsules are indicated as part of a comprehensive treatment program for attention-deficit/hyperactivity disorder (ADHD) in children over 6 years of age when remedial measures alone prove insufficient. Treatment must be under the supervision of a specialist in childhood behavioural disorders. Diagnosis should be made according to DSM-IV criteria or the guidelines in ICD-10.
Leyfisdagur:
2011-05-01
